financetom
Business
financetom
/
Business
/
Quantum Biopharma Chooses BitGo to Store Cryptocurrency Holdings
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Quantum Biopharma Chooses BitGo to Store Cryptocurrency Holdings
May 26, 2025 11:39 AM

08:47 AM EDT, 05/21/2025 (MT Newswires) -- Quantum Biopharma ( QNTM ) said Wednesday it has chosen BitGo to manage its cryptocurrency assets, including bitcoin, solana, XRP and dogecoin.

Financial terms were not provided.

The company said BitGo will provide secure storage and custody services for its digital assets using cold storage and multi-signature wallet technologies.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Turnspire Capital Partners Portfolio Company Infinity Engineered Products Acquires Meklas Otomotiv
Turnspire Capital Partners Portfolio Company Infinity Engineered Products Acquires Meklas Otomotiv
Oct 6, 2025
NEW YORK--(BUSINESS WIRE)-- Turnspire Capital Partners LLC (“Turnspire”) announced today that its portfolio company, Infinity Engineered Products (“Infinity”), the global exclusive provider of Goodyear branded air springs, has acquired Meklas Otomotiv (“Meklas”). Founded in 1986, Meklas is one of Europe’s premier air springs manufacturers primarily serving aftermarket customers globally for commercial vehicle applications. The acquisition provides significant synergy opportunities, as...
Jeffs' Brands Reports First-Half of 2025 Revenue Growth, Successful Merger and Operating Profit for its Logistics Operations
Jeffs' Brands Reports First-Half of 2025 Revenue Growth, Successful Merger and Operating Profit for its Logistics Operations
Oct 6, 2025
Tel Aviv, Israel, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd ( JFBR ) (“Jeffs’ Brands” or the “Company”) , a data-driven e-commerce company operating on the Amazon Marketplace, today reiterated its operational highlights previously announced on September 22, 2025, for the six-month period ended June 30, 2025. First half and recent highlights: Revenues for the first six months...
STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims
STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims
Oct 6, 2025
Alcon Merger Represents 59% Premium to the 90-Day VWAP Prior to the Announcement The STAAR Board of Directors Strongly Encourages ALL Stockholders to Vote “FOR” the Alcon Merger on the WHITE Proxy Card LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company ( STAA ) , the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO...
Merck Launches Three Phase 2 Trials for Tulisokibart in Inflammatory Diseases
Merck Launches Three Phase 2 Trials for Tulisokibart in Inflammatory Diseases
Oct 6, 2025
07:30 AM EDT, 10/06/2025 (MT Newswires) -- Merck ( MRK ) said Monday it has begun three phase 2 trials to evaluate its experimental therapy, tulisokibart, in patients with hidradenitis suppurativa, axial spondyloarthritis, and rheumatoid arthritis. The company said the global studies would enroll more than 640 patients. Merck ( MRK ) added that tulisokibart is now being tested in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved